Use filters to refine the search results.
Results 1-4 of 4
|18-Sep-2017||Development and internal validation of prediction models for biochemical failure and composite failure after focal salvage high intensity focused ultrasound for local radiorecurrent prostate cancer: Presentation of risk scores for individual patient prognoses.||Peters, M; Kanthabalan, A; Shah, TT; McCartan, N; Moore, CM, et al|
|18-Jul-2017||Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancer||Kanthabalan, A; Peters, M; Van Vulpen, M; McCartan, N; Hindley, RG, et al|
|Oct-2018||A multicentre study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate cancer||Guillaumier, S; Peters, M; Arya, M; Afzal, N; Charman, S, et al|
|Sep-2019||Medium‐term oncological outcomes in a large cohort of men treated with either focal or hemi‐ablation using high‐intensity focused ultrasonography for primary localized prostate cancer||Stabile, A; Orczyk, C; Hosking-Jervis, F; Giganti, F; Arya, M, et al|